https://news.sky.com/story/covid-19-the-multi-billion-pound-business-of-the-oxford-vaccine-12134833
Zwróćcie uwagę kto testuje mieszanie z kim…
Ruscy z AstraZeneca
AstraZenece z Pfizerem
Stara strategia szczepień zakłada używanie tej samej szczepionki - jak ktoś ma raz Pfizera musi mieć go cały czas. I to samo inne produkty.
https://www.hhs.gov/sites/default/files/strategy-for-distributing-covid-19-vaccine.pdf
Given that vaccine guidance in several countries states that each dose of the multidose COVID-19 vaccine must be produced by the same manufacturer as previous doses, the implication is that in the event of a need for periodic COVID-19 vaccine variants, those who initially received the Oxford-AstraZeneca vaccine would likely be required to receive that same “brand” of vaccine seasonally. In other words, those who initially received the Oxford-AstraZeneca vaccine would likely be required, not just to receive a second dose of the same “brand,” but continue receiving that same “brand” of vaccine every year. Notably, no interaction studies have yet been conducted on the interactions between the COVID-19 vaccines and other medications as well as other vaccines.
If this turns out to be the case, it would certainly behoove the Oxford-Vaccitech-AstraZeneca team to want their vaccine to be the most widely used one in the first year in order to guarantee the largest market for subsequent annual COVID-19 vaccines. This could be a possible motive behind the efforts of the Oxford-AstraZeneca partnership “to supply the entire world with the Oxford jab” and to supply the vaccine “to the most vulnerable groups to COVID-19.” This vaccine has already been purchased, even before regulatory approval, by governments around the world, including in Europe, North America, Australia and most Latin American countries.
teraz Ruscy chcą wejść na rynek po AstrzeZenece - A czemu? Bo się ludzie jej boją
i rezygnują. Jak DANIA
kasa na stole do wzięcia
#szczepionki #astrazeneca #sputnikv #biznes #dania
Zwróćcie uwagę kto testuje mieszanie z kim…
Ruscy z AstraZeneca
AstraZenece z Pfizerem
Stara strategia szczepień zakłada używanie tej samej szczepionki - jak ktoś ma raz Pfizera musi mieć go cały czas. I to samo inne produkty.
https://www.hhs.gov/sites/default/files/strategy-for-distributing-covid-19-vaccine.pdf
Given that vaccine guidance in several countries states that each dose of the multidose COVID-19 vaccine must be produced by the same manufacturer as previous doses, the implication is that in the event of a need for periodic COVID-19 vaccine variants, those who initially received the Oxford-AstraZeneca vaccine would likely be required to receive that same “brand” of vaccine seasonally. In other words, those who initially received the Oxford-AstraZeneca vaccine would likely be required, not just to receive a second dose of the same “brand,” but continue receiving that same “brand” of vaccine every year. Notably, no interaction studies have yet been conducted on the interactions between the COVID-19 vaccines and other medications as well as other vaccines.
If this turns out to be the case, it would certainly behoove the Oxford-Vaccitech-AstraZeneca team to want their vaccine to be the most widely used one in the first year in order to guarantee the largest market for subsequent annual COVID-19 vaccines. This could be a possible motive behind the efforts of the Oxford-AstraZeneca partnership “to supply the entire world with the Oxford jab” and to supply the vaccine “to the most vulnerable groups to COVID-19.” This vaccine has already been purchased, even before regulatory approval, by governments around the world, including in Europe, North America, Australia and most Latin American countries.
teraz Ruscy chcą wejść na rynek po AstrzeZenece - A czemu? Bo się ludzie jej boją
i rezygnują. Jak DANIA kasa na stole do wzięcia
#szczepionki #astrazeneca #sputnikv #biznes #dania
Brak komentarzy. Napisz pierwszy